These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 304676)

  • 1. Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.
    de Sousa M; Smithyman A; Tan C
    Am J Pathol; 1978 Feb; 90(2):497-520. PubMed ID: 304676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulations of lymph nodes and spleens in Hodgkin's disease.
    Pinkus GS; Barbuto D; Said JW; Churchill WH
    Cancer; 1978 Sep; 42(3):1270-9. PubMed ID: 308838
    [No Abstract]   [Full Text] [Related]  

  • 6. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
    Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
    Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic definition of lymphocytes: functions and markers.
    Stathopoulos G; Davies AJ
    Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of ferritin as a circulating tumor-associated antigen in Hodgkin's disease.
    Bieber CP; Bieber MM
    Natl Cancer Inst Monogr; 1973 May; 36():147-57. PubMed ID: 4582990
    [No Abstract]   [Full Text] [Related]  

  • 10. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hodgkin's disease. Histology--immunohistology--immunology].
    Möller P
    Norm Pathol Anat (Stuttg); 1986; 51():1-77. PubMed ID: 3495783
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histopathology and histogenesis of Hodgkin's disease].
    Belpomme D; Rappaport H; Mathé G
    Rev Prat; 1974 Oct; 24(45):3911-6, 3919-23. PubMed ID: 4548561
    [No Abstract]   [Full Text] [Related]  

  • 14. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryopreservation of cells for immunological typing of non-Hodgkin's lymphomas.
    Noorloos AA; van Beek AA; Melief CJ
    Cancer Res; 1980 Aug; 40(8 Pt 1):2890-4. PubMed ID: 7388838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
    Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte migration in malignant disease.
    Crowther D; Wagstaff J
    Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.